Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could sticky tape ease breast cancer swelling? new trial investigates

NCT ID NCT07080476

Symptom relief Sponsor: Universiteit Antwerpen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether adding kinesio tape to standard therapy helps women with long-term breast or trunk swelling after breast cancer treatment. About 128 participants will receive either standard care alone or standard care plus kinesio tape for four weeks. Researchers will measure changes in pain, swelling, and quality of life over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
kinesio tape
What this could lead to
If it works, this could offer a simple, non-drug way to ease pain and swelling for women with persistent lymphedema after breast cancer treatment.
What could go wrong
This is a small, early-stage trial (128 participants) testing a tape addition to standard care. The benefit may be small or not last long, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients previously treated for breast cancer. * Suffering from persistent (\>6 months) breast and/or truncal oedema, established at least six months after completion of radiotherapy. * Objective measurements: * BrEQ score ≥9. * PWC (LymphScanner) showing at least one of the following: * Truncal oedema: ratio ≥ 1.32. * Breast oedema: ratio ≥ 1.28. * Local PWC of 52.90%. * Clinical evaluation: * At least one positive sign of breast and/or truncal oedema such as: * Visual swelling compared with the contralateral side. * Visible imprint of the bra on the skin. * Peau d'orange appearance on the breast. Exclusion Criteria: * Presence of skin infections or wounds of the breast/truncal region at the time of inclusion making it impossible to apply kinesio tape. * Age under 18 years. * Not able to read and understand Dutch language. * Having received mastectomy. * Metastatic breast cancer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer related lymphoedema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Cancer Lymphedema breast neoplasm primary lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer related lymphoedema Breast cancer-related lymphedema Breast edema Truncal lymphedema

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Groeninge

    RECRUITING

    Kortrijk, 8500, Belgium

  • Ghent University Hospital

    RECRUITING

    Ghent, 9000, Belgium

  • Iridium Network

    RECRUITING

    Antwerp, 2610, Belgium

  • University of Antwerp

    RECRUITING

    Antwerp, 2000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.